Literature DB >> 10380960

Postsynaptic 5-HT1A receptors control 5-HT release in the rat medial prefrontal cortex.

J M Casanovas1, I Hervás, F Artigas.   

Abstract

5-HTt1A receptor agonists reduce the neuronal release of 5-hydroxytryptamine (5-HT) by activation of raphe 5-HT1A autoreceptors. Using in vivo microdialysis in unanesthetized rats, we show that the local application of the selective 5-HT1A receptor agonist 8-OH-DPAT decreased the 5-HT output to approximately 50% of controls in medial prefrontal cortex (mPFC) but not in dorsal hippocampus. The decrease in 5-HT output was counteracted by the concurrent application of the selective 5-HT1A receptor antagonist WAY-100635. This agent also reversed the decrease in 5-HT output elicited by the novel 5-HT1A receptor agonist BAY x 3702 (30 microM) in mPFC and dorsal raphe nucleus. These results indicate that postsynaptic 5-HT1A receptors in mPFC also participate in the control of serotonergic activity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10380960     DOI: 10.1097/00001756-199905140-00010

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  19 in total

1.  Control of serotonergic function in medial prefrontal cortex by serotonin-2A receptors through a glutamate-dependent mechanism.

Authors:  R Martín-Ruiz; M V Puig; P Celada; D A Shapiro; B L Roth; G Mengod; F Artigas
Journal:  J Neurosci       Date:  2001-12-15       Impact factor: 6.167

2.  Preferential in vivo action of F15599, a novel 5-HT(1A) receptor agonist, at postsynaptic 5-HT(1A) receptors.

Authors:  L Lladó-Pelfort; M-B Assié; A Newman-Tancredi; F Artigas; P Celada
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

3.  Serotonin Signaling through Prefrontal Cortex 5-HT1A Receptors during Adolescence Can Determine Baseline Mood-Related Behaviors.

Authors:  Alvaro L Garcia-Garcia; Qingyuan Meng; Sarah Canetta; Alain M Gardier; Bruno P Guiard; Christoph Kellendonk; Alex Dranovsky; E David Leonardo
Journal:  Cell Rep       Date:  2017-01-31       Impact factor: 9.423

4.  Intra-prefrontal 8-OH-DPAT and M100907 improve visuospatial attention and decrease impulsivity on the five-choice serial reaction time task in rats.

Authors:  Catharine A Winstanley; Yogita Chudasama; Jeffrey W Dalley; David E H Theobald; Jeffrey C Glennon; Trevor W Robbins
Journal:  Psychopharmacology (Berl)       Date:  2003-04-02       Impact factor: 4.530

5.  Preclinical and clinical characterization of the selective 5-HT(1A) receptor antagonist DU-125530 for antidepressant treatment.

Authors:  M C Scorza; L Lladó-Pelfort; S Oller; R Cortés; D Puigdemont; M J Portella; R Pérez-Egea; E Alvarez; P Celada; V Pérez; F Artigas
Journal:  Br J Pharmacol       Date:  2012-11       Impact factor: 8.739

6.  Differential role of 5-HT1A and 5-HT1B receptors on the antinociceptive and antidepressant effect of tramadol in mice.

Authors:  Esther Berrocoso; M Olga Rojas-Corrales; Juan A Mico
Journal:  Psychopharmacology (Berl)       Date:  2006-07-11       Impact factor: 4.530

7.  Control of dorsal raphe serotonergic neurons by the medial prefrontal cortex: Involvement of serotonin-1A, GABA(A), and glutamate receptors.

Authors:  P Celada; M V Puig; J M Casanovas; G Guillazo; F Artigas
Journal:  J Neurosci       Date:  2001-12-15       Impact factor: 6.167

Review 8.  Genetic approaches for understanding the role of serotonin receptors in mood and behavior.

Authors:  Zoe R Donaldson; Katherine M Nautiyal; Susanne E Ahmari; René Hen
Journal:  Curr Opin Neurobiol       Date:  2013-02-04       Impact factor: 6.627

9.  Control of the serotonergic system by the medial prefrontal cortex: potential role in the etiology of PTSD and depressive disorders.

Authors:  Pau Celada; M. Victoria Puig; Raúl Martín-Ruiz; Josep M. Casanovas; Francesc Artigas
Journal:  Neurotox Res       Date:  2002 Aug-Sep       Impact factor: 3.911

Review 10.  Genetic variation in cortico-amygdala serotonin function and risk for stress-related disease.

Authors:  Andrew Holmes
Journal:  Neurosci Biobehav Rev       Date:  2008-03-26       Impact factor: 8.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.